KORU Medical Systems, Inc. Common Stock (DE)

Day range

$3.15 – $3.27

Open

$3.18

Prev close

$3.17

Volume

116.02K

Market cap

$146.36M

Shares out

45.93M

P/E

—

P/S

3.24

P/B

8.11

P/FCF

188.46

ROE

-10.1%

ROA

-6.5%

Debt/Equity

0.01

Div yield

0.00%

As of Oct 23, 2026

• Bylaw amendmentAug 14, 2026

  Effective August 13, 2026, the Board of Directors unanimously adopted a resolution to amend Section 3.05 of the Company's Amended and Restated By-laws to state that, in compliance with the Delaware General Corporation Law, the authority to remove a director from the Board is vested exclusively in the affirmative vote of shareholders holding a majority of the Company's outstanding shares.

• Guidance issuance or updateAug 5, 2026

  On August 5, 2026, KORU Medical Systems, Inc. (the "Company") issued a press release announcing its financial results for the second fiscal quarter ended June 30, 2026 and updating financial guidance for the fiscal year ended December 31, 2025.

• Supply or distribution agreementJun 30, 2026

  On June 24, 2026, KORU Medical Systems, Inc. (the "Company") entered into that certain Amendment No. 1 to Amended and Restated Manufacturing and Supply Agreement (the "Amendment") with Command Medical Products, LLC ("Command"), which amends that certain Amended and Restated Manufacturing and Supply Agreement dated January 1, 2024 between the Company and Command (the "Agreement"). Under the Agreement, Command manufactures and supplies the Company's subassemblies, needle sets and tubing products pursuant to the Company's specifications and purchase orders (the "Products").

• Annual meeting resultsMay 21, 2026

  Set forth below are the voting results from the 2026 Annual Meeting of Shareholders held on May 19, 2026: Total shares voted: 36,678,784. Proposal 1: Election of Directors. The nominees for director set forth under 'Nominees' below were elected to the Company's board of directors.

• Guidance issuance or updateMay 6, 2026

  issued a press release announcing its financial results for the first fiscal quarter ended March 31, 2026 and reiterating financial guidance for the fiscal year ended December 31, 2026.

Days to cover

2.5

Short interest

907.39K

Avg volume

356.63K

As of Sep 30, 2026 · reported to FINRA twice monthly.

• Reasons to Retain Doximity Stock in Your Portfolio for Now
  neutralZacks Investment Research· Oct 5, 2026
• Cirtec Medical Announces Appointment of New Chief Executive Officer
  neutralGlobeNewswire Inc.· Aug 28, 2025
• KORU Medical Systems Inc. (KRMD) Reports Q1 Loss, Tops Revenue Estimates
  Zacks Investment Research· May 1, 2024
• ClearPoint Neuro, Inc. (CLPT) Reports Q4 Loss, Tops Revenue Estimates
  Zacks Investment Research· Mar 12, 2024
• KORU Medical (KRMD) Forms New Deal on Subcutaneous Infusion
  Zacks Investment Research· Mar 12, 2024